Median Technologies SA (ALMDT.PA)
EUR 3.55
(-2.74%)
EUR 3.55
(-2.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -19.58 Million EUR | 2.17% |
| 2022 | -17.47 Million EUR | -112.25% |
| 2021 | -16.94 Million EUR | -26.75% |
| 2020 | -11.2 Million EUR | -12.53% |
| 2019 | -7.34 Million EUR | 49.61% |
| 2018 | -14.52 Million EUR | 13.51% |
| 2017 | -16.8 Million EUR | -93.12% |
| 2016 | -8.78 Million EUR | -61.52% |
| 2015 | -5.43 Million EUR | 0.06% |
| 2014 | -4.32 Million EUR | -17.41% |
| 2013 | -4.61 Million EUR | -0.0% |
| 2012 | -4.54 Million EUR | -10.28% |
| 2011 | -4.03 Million EUR | -12.01% |
| 2010 | -3.65 Million EUR | 10.64% |
| 2009 | -4.17 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -11.86 Million EUR | 0.0% |
| 2023 Q2 | -10.62 Million EUR | 0.0% |
| 2023 Q4 | -11.95 Million EUR | 0.0% |
| 2023 FY | - EUR | 2.17% |
| 2022 Q4 | -12.07 Million EUR | 0.0% |
| 2022 FY | - EUR | -112.25% |
| 2022 Q2 | -10.47 Million EUR | 0.0% |
| 2021 Q4 | -6.74 Million EUR | 0.0% |
| 2021 FY | - EUR | -26.75% |
| 2021 Q2 | -4.12 Million EUR | 0.0% |
| 2020 Q2 | -4.09 Million EUR | 0.0% |
| 2020 Q4 | -3.89 Million EUR | 0.0% |
| 2020 FY | - EUR | -12.53% |
| 2019 Q2 | -3.87 Million EUR | 0.0% |
| 2019 FY | - EUR | 49.61% |
| 2019 Q4 | -3.53 Million EUR | 0.0% |
| 2018 Q4 | -5.84 Million EUR | 0.0% |
| 2018 FY | - EUR | 13.51% |
| 2018 Q2 | -8.88 Million EUR | 0.0% |
| 2017 FY | - EUR | -93.12% |
| 2017 Q4 | -8.61 Million EUR | 0.0% |
| 2017 Q2 | -8.19 Million EUR | 0.0% |
| 2016 FY | - EUR | -61.52% |
| 2016 Q2 | -3.56 Million EUR | 0.0% |
| 2016 Q4 | -5.49 Million EUR | 0.0% |
| 2015 Q2 | -2.51 Million EUR | 0.0% |
| 2015 FY | - EUR | 0.06% |
| 2015 Q4 | -3.08 Million EUR | 0.0% |
| 2014 FY | - EUR | -17.41% |
| 2014 Q4 | -2.31 Million EUR | 0.0% |
| 2014 Q2 | -2.08 Million EUR | 0.0% |
| 2013 Q2 | 806 Thousand EUR | 0.0% |
| 2013 Q4 | -4.47 Million EUR | 0.0% |
| 2013 FY | - EUR | -0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | - EUR | -10.28% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | - EUR | -12.01% |
| 2010 FY | - EUR | 10.64% |
| 2009 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Affluent Medical SA | -13.34 Million EUR | -46.781% |
| Bluelinea Société Anonyme | -323.98 EUR | -6045026.242% |
| Carmat SA | -50.45 Million EUR | 61.181% |
| Diagnostic Medical Systems S.A. | -7.05 Million EUR | -177.526% |
| Euromedis Groupe | -4.43 Million EUR | -341.582% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 203.155% |
| Ikonisys S.A. | -2.34 Million EUR | -734.283% |
| Implanet S.A. | -5.07 Million EUR | -285.759% |
| SpineGuard SA | -3.49 Million EUR | -460.08% |
| Theraclion SA | -4.48 Million EUR | -336.46% |
| Euroapi S.A. | -155.39 Million EUR | 87.397% |
| Guerbet SA | 98.83 Million EUR | 119.815% |
| Ion Beam Applications SA | 12.53 Million EUR | 256.305% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 101.881% |
| Sequana Medical NV | -29.13 Million EUR | 32.783% |